SCHEMBL17150262

SCHEMBL17150262

c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccc([Si](c3ccccc3)(c3ccccc3)c3cccc(-n4c5ccccc5n5c6ccccc6nc45)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
ADORA1 P30542 4/20 0.35
ADORA2B P29275 1/20 0.35
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
TSHR P16473 2/20 0.34
ADORA3 P0DMS8 3/20 0.33
ADORA2A P29274 3/20 0.33
LCK P06239 2/20 0.33
SRC P12931 2/20 0.33
CRHBP P24387 1/20 0.33
RECQL P46063 1/20 0.33
CRHR2 Q13324 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17150259 1.00 MAPK1 (0.38) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL17150243 0.99 MAPK1 (0.39) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL18701288 0.99 MAPK1 (0.39) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL17150268 0.97 MAPK1 (0.38) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL18407031 0.95 MAPK1 (0.38) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL17150239 0.95 MAPK1 (0.36) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL26519482 0.94 MAPK1 (0.40) MAPK1HTTADORA1KDM4EALDH1A1
SCHEMBL18701346 0.94 MAPK1 (0.35) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL17150237 0.94 MAPK1 (0.35) MAPK1HTTADORA1ADORA2BKDM4E
SCHEMBL18701354 0.94 MAPK1 (0.35) MAPK1HTTADORA1ADORA2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170025627-A1 SILYL-BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE AS HOST FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-01-26 US disclosed
US-20170025627-A1 SILYL-BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE AS HOST FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-01-26 US disclosed
WO-2015150234-A1 SILYL-BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE AS HOST FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170025627-A1 SILYL-BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE AS HOST FOR ORGANIC LIGHT EMITTING DIODES CCNI, SLCO4C1, SLCO2A1 MAPK1 950/4885HTT 2364/4885ADORA1 2866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.